A股異動 | 融捷健康(300247.SZ)漲超6% 擬出售瑞宇健身全部股權
格隆匯6月9日丨融捷健康(300247.SZ)現報2.63元,漲幅6.48%,最新總市值21.15億。公司昨日公告稱,為優化公司資產結構和資源配置,公司擬將全資子公司上海瑞宇健身休閒用品有限公司100%股權以人民幣3500萬元的價格轉讓給陳偉,交易完成後,公司將不再持有瑞宇健身股權。瑞宇健身最近一年一期的報表均處於虧損狀態,公司出售瑞宇健身100%股權,有利於公司減輕經營負擔、充實現金流、優化資產配置,更好地保護投資者利益。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.